Serial #79367537
LIVE

Serial Number

79367537

Owner

MILEUTIS LTD

Attorney

Jacqueline Zion

Filing Date

Mar 21, 2023

Add to watchlist:

No watchlists yet
View on USPTO

Serial #79367537 Trademark

Serial Number: 79367537 • Registration: 7636536

Serial #79367537 is a trademark filed by MILEUTIS LTD on March 21, 2023. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

MILEUTIS LTD (4 trademarks)

7 Golda Meir

Entity Type: 99

Trademark Details

Filing Date

March 21, 2023

Registration Date

January 7, 2025

Published for Opposition

September 17, 2024

Goods & Services

Intramammary and intrauterine veterinary preparations for treating mastitis, mammary infections, uterine infections, myometrium infection and intrauterine infections; intramammary and intrauterine pharmaceutical and medical preparations for human use for treating mastitis, mammary infections, and intrauterine infections; pharmaceutical preparations, veterinary preparations, and medical preparations for the treatment and prevention of mastitis, breast inflammation, mammary infections and mammary inflammation; pharmaceutical preparations, veterinary preparations, and medical preparations for the treatment and prevention of metritis; pharmaceutical preparations, veterinary preparations, and medical preparations for the prevention and treatment of uterine infections; veterinary preparations for increasing milk production and improving feed efficiency, namely for treating gastro-intestinal diseases, anorexia, and for use as growth promoters; animal feed additive for use as a nutritional supplement for medical purposes; pharmaceutical and medical preparations for increasing milk production, namely for treating mastitis, mammary infections, and for involution of the mammary glands; veterinary preparations for the prevention and treatment of bacterial infections; pharmaceutical preparations and medical preparations for the prevention and treatment of bacterial infections; pharmaceutical preparations, veterinary preparations and medical preparations for mammary and udder involution; pharmaceutical preparations, veterinary preparations and medical preparations for reduction of somatic cell count in milk, namely for treating mammary and udder inflammations; veterinary preparations, and pharmaceutical preparations for increasing the welfare and comfort of lactating animals, namely, to reduce, eliminate and treat symptoms related to infections in lactating animals during the lactation period; veterinary and pharmaceutical preparations for increasing the welfare and comfort of lactating animals, namely, to reduce, eliminate and treat symptoms involved with the dry-off period in lactating animals, namely for treating mammary pain, mammary infections, and edema; pharmaceutical and medical preparations for the prevention and treatment of lactation-related medical conditions, namely for treating mammary pain, mammary infections, and edema; pharmaceutical preparations, veterinary preparations and medical preparations for the treatment and prevention of infections in poultry, and for use as growth promoters of poultry; pharmaceutical and medical preparations for the prevention or treatment of buccal diseases, disorders and conditions, namely mucositis and buccal infections; pharmaceutical and medical preparations for the prevention or treatment of central, peripherical and neuronal nervous systems diseases; pharmaceutical and medical preparations for the prevention or treatment of gastro-intestinal diseases; pharmaceutical and medical preparations for the prevention or treatment of diseases of the musculo-skeletal system; medical and veterinary preparations to regulate and adapt the mammalian gut microbiome for disease prevention and wellness; pharmaceutical preparations, medical preparations, and veterinary preparations for the treatment of wounds, and damages to the skin and tissues, namely skin and tissue infections; pharmaceutical preparations, medical preparations, and veterinary preparations for the prevention and treatment of dermatological disorders, and skin diseases, related to hyperactive immune response, or allergies; pharmaceutical preparations, medical preparations, and veterinary preparations for the prevention and treatment of immunostimulation and immunomodulation; synthetic and biological peptides for the treatment of immunostimulation, and immunomodulation; pharmaceutical, medical and veterinary preparations to regulate and adapt the mammalian buccal, gastrointestinal and vaginal-vulvar microbiome for disease prevention and wellness

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Jul 19, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jul 2, 2025 FICS
FINAL DISPOSITION PROCESSED
Jul 2, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 7, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 7, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 7, 2025 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Sep 30, 2024 OPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 17, 2024 NPUB
PUBLISHED FOR OPPOSITION
Sep 17, 2024 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 11, 2024 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Sep 11, 2024 OPNR
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 28, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 14, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 19, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 19, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 19, 2024 TROA
REFUSAL PROCESSED BY IB
Jan 8, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 21, 2023 RFCS
REFUSAL PROCESSED BY MPU
Dec 21, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 17, 2023 RFCR
NON-FINAL ACTION WRITTEN
Dec 16, 2023 CNRT
ASSIGNED TO EXAMINER
Dec 16, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Apr 21, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 17, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 13, 2023 REPR